1. Home
  2. KORE vs TIL Comparison

KORE vs TIL Comparison

Compare KORE & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORE Group Holdings Inc.

KORE

KORE Group Holdings Inc.

HOLD

Current Price

$4.89

Market Cap

83.3M

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$7.09

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KORE
TIL
Founded
2003
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
74.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
KORE
TIL
Price
$4.89
$7.09
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$5.00
$125.00
AVG Volume (30 Days)
50.4K
267.1K
Earning Date
11-12-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$285,408,000.00
N/A
Revenue This Year
$1.26
N/A
Revenue Next Year
$7.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.06
N/A
52 Week Low
$2.00
$5.67
52 Week High
$5.03
$42.79

Technical Indicators

Market Signals
Indicator
KORE
TIL
Relative Strength Index (RSI) 59.25 32.23
Support Level $4.54 $6.96
Resistance Level $5.03 $7.29
Average True Range (ATR) 0.22 0.51
MACD -0.01 0.03
Stochastic Oscillator 81.38 20.37

Price Performance

Historical Comparison
KORE
TIL

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: